Streptococcus bovis/Streptococcus equinus complex fecal carriage, colorectal carcinoma, and infective endocarditis: a new appraisal of a complex connection

2013 ◽  
Vol 32 (9) ◽  
pp. 1171-1176 ◽  
Author(s):  
C. Chirouze ◽  
I. Patry ◽  
X. Duval ◽  
V. Baty ◽  
P. Tattevin ◽  
...  
Keyword(s):  
Infective Endocarditis ◽  
Colorectal Carcinoma ◽  
Streptococcus Bovis ◽  
Fecal Carriage ◽  
Streptococcus Equinus

scholarly journals A prospective controlled study of the association of Streptococcus bovis with colorectal carcinoma

1998 ◽  
Vol 51 (6) ◽  
pp. 473-474 ◽  
Author(s):  
M. A. Potter ◽  
N. A. Cunliffe ◽  
M. Smith ◽  
R. S. Miles ◽  
A. D. Flapan ◽  
...  
Keyword(s):  
Colorectal Carcinoma ◽  
Controlled Study ◽  
Streptococcus Bovis ◽  
Prospective Controlled Study

scholarly journals Draft Genome Sequence of Streptococcus equinus (Streptococcus bovis) HC5, a Lantibiotic Producer from the Bovine Rumen

2015 ◽  
Vol 3 (2) ◽  
Author(s):  
Analice C. Azevedo ◽  
Cláudia B. P. Bento ◽  
Jeronimo C. Ruiz ◽  
Marisa V. Queiroz ◽  
Hilário C. Mantovani
Keyword(s):  
Genome Sequence ◽  
Draft Genome ◽  
Draft Genome Sequence ◽  
Streptococcus Bovis ◽  
Bovine Rumen ◽  
Streptococcus Bovis Hc5 ◽  
Streptococcus Equinus

scholarly journals An Overview on Streptococcus bovis/Streptococcus equinus Complex Isolates: Identification to the Species/Subspecies Level and Antibiotic Resistance

2019 ◽  
Vol 20 (3) ◽  
pp. 480 ◽  
Author(s):  
Arianna Pompilio ◽  
Giovanni Di Bonaventura ◽  
Giovanni Gherardi
Keyword(s):  
Antibiotic Resistance ◽  
Streptococcus Bovis ◽  
Accurate Identification ◽  
Carriage Rate ◽  
Antibiotic Resistant ◽  
Resistant Species ◽  
Subspecies Level ◽  
Resistance Rates ◽  
Group D ◽  
Streptococcus Equinus

Streptococcus bovis/Streptococcus equinus complex (SBSEC), a non-enterococcal group D Streptococcus spp. complex, has been described as commensal bacteria in humans and animals, with a fecal carriage rate in humans varying from 5% to over 60%. Among streptococci, SBSEC isolates represent the most antibiotic-resistant species—with variable resistance rates reported for clindamycin, erythromycin, tetracycline, and levofloxacin—and might act as a reservoir of multiple acquired genes. Moreover, reduced susceptibility to penicillin and vancomycin associated with mobile genetic elements have also been detected, although rarely. Since the association of SBSEC bacteremia and colon lesions, infective endocarditis and hepatobiliary diseases has been established, particularly in elderly individuals, an accurate identification of SBSEC isolates to the species and subspecies level, as well as the evaluation of antibiotic resistance, are needed. In this paper, we reviewed the major methods used to identify SBSEC isolates and the antimicrobial resistance rates reported in the scientific literature among SBSEC species.

Effects of Diet on Ungulate Excretion of Enterococcus spp., Streptococcus bovis, and Streptococcus equinus in Feces

1995 ◽  
Vol 24 (4) ◽  
pp. 719-724 ◽  
Author(s):  
Neal W. Darby ◽  
Jeffrey C. Mosley ◽  
Bruce B. Davitt ◽  
Gregory A. Bohach
Keyword(s):  
Streptococcus Bovis ◽  
Enterococcus Spp ◽  
Streptococcus Equinus

Infective endocarditis due to penicillin-tolerant Streptococcus bovis

1986 ◽  
Vol 5 (2) ◽  
pp. 171-176 ◽  
Author(s):  
Joan C. Fung ◽  
Joseph J. Gadbaw ◽  
Sam T. Donta ◽  
Richard C. Tilton
Keyword(s):  
Infective Endocarditis ◽  
Streptococcus Bovis

scholarly journals A severe infective endocarditis successfully treated with linezolid

2010 ◽  
Vol 4 (1) ◽  
pp. 39-48
Author(s):  
Graziano Antonio Minafra ◽  
Donatella Concetta Cibelli ◽  
Maria Pipino ◽  
Vincenzo Dargenio ◽  
Francesco Ventrella
Keyword(s):  
Infective Endocarditis ◽  
Soft Tissue ◽  
Standard Therapy ◽  
Prosthetic Valve ◽  
Prosthetic Valve Endocarditis ◽  
Multidrug Resistant ◽  
Bacterial Endocarditis ◽  
Soft Tissue Infections ◽  
Streptococcus Bovis ◽  
Gram Positive Cocci

Despite significant improvements in surgical and medical therapy, prosthetic valve endocarditis (PVE) is a diagnostic and therapeutic challenge and is often associated with a severe prognosis. We report a case of a 59-year-old woman, with  PVE and bacterial endocarditis (Streptococcus bovis) successfully treated with linezolid. Linezolid is a bacteriostatic oxazolidinone antibiotic that has been proven to be effective for the treatment of patients with pneumonia, skin and soft tissue infections, and infections due to Gram-positive cocci. Linezolid is not yet recognised as a standard therapy for infective endocarditis, but its use becomes a necessity when infection is due to multidrug-resistant microorganisms.

Sign in / Sign up

Export Citation Format

Share Document